Digest: Egorov 2013 — Transcranial Laser + Magnetic Therapy in Glaucoma
(Click to Expand)
Clinical takeaway: In 165 glaucomatous eyes, combined transcranial low-intensity laser + magnetic therapy (vs magnetic alone) produced larger, more significant gains — expanded visual fields, reduced scotomas, stronger VEPs, and improved ocular blood flow.
Summary:
This study used infrared laser with a magnetic field transcranially. Patients showed measurable field enlargement, scotoma reduction, and improved conduction (VEP). Doppler confirmed better ocular blood flow through reduced resistance in the short posterior ciliary arteries.
Though focused on glaucoma, the mechanisms — conduction and perfusion — are relevant in other optic-nerve compromise.
📂 Expand Data & Methods
Data & Methods
-
Design & Population: 165 eyes with primary open-angle glaucoma (POAG), stages I–III.
-
Intervention:
- Group 1: Combined transcranial magneto-laser therapy — low-intensity IR laser (wavelength ~0.85 μm) + weak magnetic field (~14-40 mT), applied bitemporally over visual pathways.
- Group 2: Magnetic therapy only.
-
Outcomes:
- Compared to magnetic therapy alone, the combined method led to:
- Visual fields: Average expansion +56% (range 38–74% by stage), with scotomas disappearing in 58% of cases (vs 22% with magnet alone).
- Electrophysiology: VEP amplitude rose 21–41%, across stages (most pronounced in early-stage POAG); latency shortened up to 15 ms in stage I.
- Ocular blood flow: Resistance index (Ri) in short posterior ciliary arteries reduced by 15–25% across stages; average improvement 19.3%.
- Compared to magnetic therapy alone, the combined method led to:
-
Statistical significance: All key findings p < 0.05.
👉 If you want access to full abstracts, translations, or methodological notes, →📨 email us.
👉 To see how this research connects to real cases in practice, explore the Clinical Case Gallery